Resultados de la búsqueda 21-30 of 1774 for Off-label

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast or recurred after ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

  4. Nutrición y comida saludable - Mayo Clinic

    enero 2025. Don't miss a quiet symptom of concussion Jan. 21, 2025, 05:00 p.m. CDT · Mayo Clinic Minute: New rule for 'healthy' food labels Jan. 20, 2025, 03 ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... away from work. Participant eligibility includes ... This phase 1b trial is an open-label study ... This open-label, randomized study will compare ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purposes of this study are (i) to obtain and study biospecimens from patients with breast cancer that has either spread out of the breast or recurred after ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This phase 1b trial is an open-label study designed to assess the safety, tolerability, and preliminary antitumor activity of REGN5458 in ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...